X-ray Talbot-Lau interferometry is one of the x-ray phase imaging methods that has high sensitivity in depicting soft tissues. Unlike earlier x-ray phase imaging methods that required particular types of x-ray sources, such as a synchrotron or a micro-focus x-ray tube, x-ray Talbot-Lau interferometry enables to perform clinical x-ray phase imaging using a conventional x-ray source with a relatively compact configuration. We developed an apparatus to depict cartilage in the metacarpophalangeal joints of the hands. In addition, we examined the apparatus performance by applying it to healthy volunteers and patients with rheumatoid arthritis (RA). Cartilage deformation, which is thought to be a precursor of destruction of the joints, was successfully depicted by the apparatus, suggesting a potential early diagnosis of RA.
X-ray phase imaging is a promising method for depicting soft tissues because of its high sensitivity to materials consisting of light elements1. However, its clinical application has not yet been reported because it requires a coherent x-ray source, such as a huge synchrotron radiation source. X-ray grating interferometry or x-ray Talbot interferometry was demonstrated by Momose et al. for x-ray phase imaging2, making a breakthrough in this problem because a micro-focus x-ray source became available. However, the power of micro-focus X-ray sources is insufficient for clinical use. Talbot-Lau interferometry, which is a modification of Talbot interferometry, was first suggested by Clauser et al.3 and constructed for x-rays by Pfeiffer et al.4. This opened up the possibility for the development of clinical imaging apparatuses, which can be operated in a normal x-ray room with a conventional x-ray tube. X-ray phase imaging method acquires phase-contrast pictures by a digital image sensor and produces quantitative images after computer image processing2,4.
In the medical field, some animal and ex vivo human studies focused on depicting breast cancer5, lung diseases6, and brain diseases7. We, as well as Muehleman et al. and Stutman et al.8,9, have focused on depicting the limbs cartilage. After confirming the depiction on a cadaver and healthy volunteers10,11, we started the first clinical study on depicting the cartilage in patients with arthritis. We aimed to early diagnose rheumatoid arthritis (RA). Thanks to biological agents, such as anti-tumour necrosis factor (TNF)-alpha biologics and non-TNF biologics, which have evolved recently following disease-modifying antirheumatic drugs12,13, an early diagnosis, expected by the phase-imaging apparatus and successful treatments with biological agents, would be effective in suppressing progression of joint destruction.
In the present study, the apparatus based on Talbot-Lau interferometry11 was used to measure cartilage in the metacarpophalangeal (MP) joints of healthy volunteers and patients with RA. We also employed a magnetic resonance imaging (MRI) scanner for comparison. This study aimed to determine the benefit of using the apparatus to evaluate patients with RA.
Images of healthy volunteers and RA patients
We examined 2 MP joints selected from the index, middle, or ring finger per subject (140 joints in 70 patients, 110 joints in 55 healthy volunteers). The summary of depiction and the demographic background of the participants are shown in Table 1. Images of the left index and middle fingers of a healthy volunteer are shown in Fig. 1: (a) attenuation image, (b) small-angle-scattering image, (c) refraction image, and (d) MRI scan. The cartilage of the distal metacarpal is depicted in the refraction image, which is confirmed by comparing it with the MRI image. This result was consistent with those obtained from a cadaver and a healthy volunteer, reported previously11.
The cartilage in 79 joints was properly depicted and measured, and we were unable to measure the cartilage in other joints. One reason for this was that the cartilage was obstructed by the metacarpal bone due to insufficient finger stretch by the holder (133 joints) Fig. 1(e). Another reason was the artefact caused by the patients movement during the exposure (17 joints) (Fig. 1(f)).
The background, of the representative patients with RA named patients A and B, is shown in Table 2. The patients A and B images are shown in Figs. 2(a–e) and 3(a–e), respectively. In Figs. 2(e) and 3(e), conventional x-ray images that were used to evaluate Larsen grade are shown. We found that the cartilage was thin in the ring finger of patient A, as the yellow arrows in Fig. 2(c) indicate. Additionally, we observed partial cartilage deformation in the middle finger of patient B, as indicated by the yellow arrows in Fig. 3(c). The ring finger of patient B seemed obscured in a comparison with the images of a healthy volunteer in Fig. 1(c). MRI images that are shown in Figs. 2(d) and 3(d) also depict the cartilage thinning in the ring finger of patient A, and middle and ring fingers of patient B, suggesting that the findings by our apparatus were consistent with those of the MRI.
Thickness of the cartilage
Cartilage thickness, measured by the procedure, is described in the Methods section and shown in Fig. 4(a–c). A significant difference was found in the cartilage thickness between the healthy volunteers and patients with RA; the difference between the minimum thickness (minimum area) and average thickness (whole area) is remarkable. Since 98% of the measured fingers of patients were scored as grade 0 or grade I by Larsen Grade, the difference suggests that the apparatus could properly detect early deformation of the joints in RA patients.
Destroyed joints of patients with RA are generally irreparable. It was thought that joint destruction became remarkable within 5 years after the first appearance of symptoms14,15,16. Recently, it has been reported that destruction starts at 3 months after the first appearance of symptoms, and there is a possibility of preventing destruction with the use of methotrexate and biological agents at an early stage12,17. Therefore, it is important to detect the destruction as early as possible to diagnose RA and prevent deterioration of patients’ quality of life18. Seemingly, our apparatus is capable of detecting cartilage deformation as a precursor of joint destruction and expected to contribute to early determination of necessary medications required for proper treatment.
In general, conventional x-ray is used to evaluate RA, and the use of ultrasonic diagnostic equipment and MRI has been studied for evaluating RA19,20. Ultrasonic equipment is useful in diagnosing precise disease activity and remission due to its excellent sensitivity to synovitis. However, there are still some difficulties in introducing the equipment into diagnostic routines for outpatients because it has a longer inspection time than that by conventional methods, such as conventional x-ray. Furthermore, it requires skills for obtaining stable results. MRI has advantages in diagnosing RA in early stages, but it is also difficult to utilise the technology routinely because of long scan times and high initial costs for installation21.
We consider that our presented apparatus has a superior capability for early RA diagnosis. In addition, it is applicable to the daily clinic setting if improvements are made to the apparatus; that is, shortening the exposure time, expanding the field of view (FOV), and increasing the tube voltage to image thicker body parts other than the fingers.
In this paper, a preliminary summary of a clinical study was presented with more than 100 healthy volunteers and patients with RA. Significance of the x-ray phase-imaging apparatus has been demonstrated. Following this, detailed examination for early RA diagnosis will be continued by classifying imaging results by patients’ age, sex, and features.
This study was approved by the institutional review ethics board of Saitama Medical University in Japan (application number: 692), and a written informed consent was obtained from each participant. The study was conducted in accordance with relevant guidelines and regulations.
We used the apparatus for clinical use of Talbot-Lau interferometry11, of which the fundamental design was based on the simulation by Yashiro et al.22. The apparatus is shown in Fig. 5(a), which comprised an x-ray tube, a flat panel detector (FPD), a source grating (G0), a phase grating (G1), and an amplitude grating (G2). In addition, the FPD and the gratings are set in the housing of the apparatus. The x-ray tube (UH-6QC-307E; Hitachi Medical Corporation) had a tungsten anode and a nominal focal spot of 400 µm. The tube located above G0 was operated at 40 kVp and emitted x-rays downward. The x-ray mean photon energy was 28 keV. The specifications of the linear gratings mounted on the apparatus are shown in Table 3. The distance between G0 and G1 was 1.1 m, and that between G0 and G2 was 1.36 m. The FPD (Anrad, LMAM) was located beneath G2, and its pixel size was 85 µm. A target was placed 60 mm above G1, and the FOV was 46 mm × 46 mm, taking into account the magnification of the image when depicting the MP joints11. The values of modulation transfer function of the apparatus were 0.96 at 1 line/mm and 0.86 at 2 lines/mm in the width, and 0.92 at 1 line/mm and 0.73 at 2 lines/mm in the length at the position of the target. The apparatus was totally confirmed to satisfy the safety standards as a conventional x-ray system.
The apparatus generated three kinds of images by the fringe-scanning method1; an attenuation image, a differential phase (or refraction) image, and a small-angle-scattering (or dark-field) image23. In this study, refraction images, which map the degree of x-ray deflection caused by the refraction in subjects, were evaluated in terms of the sensitivity to cartilage tissue. The period for the imaging sequence was 32 seconds, including 19 seconds of total x-ray exposure.
We focused on capturing images of the cartilage in MP joints of the fingers, which were the predilection sites of RA. We designed a holder to hold the participant’s wrist and each proximal phalanx so that the MP joints were positioned at a proper orientation for imaging. The holder, shown in Fig. 5(b), is equipped with a mechanism for adjusting the joint space that moderately stretched the subject’s fingers.
We also designed a phantom made of polymethyl methacrylate (PMMA) and a water solution (10.5% water) of dipotassium hydrogen phosphate (K2HPO4) so that the refractive-index difference between them was the same as that between the cartilage and joint fluid24. The phantom had round columns of PMMA measuring 10 mm in diameter; it was immersed in the water solution, and the thickness of the phantom was determined to be equivalent with the attenuation of x-rays through the finger joints, as shown in Fig. 5(c). We acquired images of the phantom at the same height as that for MP joint measurements and determined the dose as 4 mGy for human subjects to satisfy a signal-to-noise ratio larger than 3.0. The signal was defined as the averaged signal by refraction between the column and water solution in 50 pixels, and the noise was defined as standard division of the signal of the water solution in 50 × 50 pixels. The refraction images of the phantom with a 4 mGy dose and the signal to noise ratio are shown in Fig. 5(d,e). Peripheral areas showed high noise because of the reduction of the x-ray caused by gratings made on flat substrates.
Evaluation of the cartilage
We performed in vivo imaging of MP joints in 55 healthy volunteers and 70 patients with RA. We evaluated the condition of the cartilage in all fingers by measuring the thickness in the whole area and minimum area. The thickness in the whole area implies that the value averaged 17.8 mm along the cartilage surface in a refraction image. The thickness in the minimum area was the average value of 0.36 mm along the thinnest cartilage surface. The procedure of the thickness evaluation is shown in Fig. 6. First, the centre of curvature of the cartilage surface, depicted in a refraction image, was found (Fig. 6(a)). Then, the image was converted so that the surface of the cartilage was almost flat (Fig. 6(b)). The thickness was evaluated by measuring the distance between the peaks appearing in the averaged profile (Fig. 6(c)). The peaks were attributed to the surfaces of cartilage and bone. The range for profile averaging was 17.8 mm for the whole area thickness, as indicated by the yellow rectangle in Fig. 6(b). The joints of patients with RA were also evaluated by the Larsen grade with conventional x-rays24. Twenty-one patients were also examined by a 3-Tesla whole-body magnetic resonance scanner (SIEMENS, Skyra). For finger MRI, fat-saturated proton density weighted images with a time of repetition/time of echo of 2500/16 ms, FOV of 80 mm, and section thickness of 1.3 mm were obtained.
The datasets generated during and/or analysed during the current study are available from the corresponding author on reasonable request.
Momose, A. Recent advances in x-ray phase imaging. Jpn. J. Appl. Phys. 44, 6355–6367 (2005).
Momose, A. et al. Demonstration of x-ray Talbot interferometry. Jpn. J. Appl. Phys. 42, L866–L868 (2003).
Clauser, J. F. & Li, S. Talbot-vonLau atom interferometry with cold slow potassium. Phys. Rev. A. 49, R2213–R2216 (1994).
Pfeiffer, F., Weitkamp, T., Bunk, O. & David, C. Phase retrieval and differential phase-contrast imaging with low-brilliance x-ray sources. Nat. Phys. 2, 258–261 (2006).
Grandl, S. et al. Improved visualization of breast cancer features in multifocal carcinoma using phase-contrast and dark-field mammography: an ex vivo study. Eur. Radiol. 25, 3659–3668 (2015).
Hellbach, K. et al. In vivo dark-field radiography for early diagnosis and staging of pulmonary emphysema. Invest. Radiol. 50, 430–435 (2015).
Lwin, T. T. et al. Spontaneous brain tumor imaging of aged rat by crystal X-ray interferometer-based phase-contrast X-ray CT. Acta Radiol. Open. 5, 2058460115626958 (2016).
Muehleman, C. et al. In-laboratory diffraction-enhanced X-ray imaging for articular cartilage. Clin. Anat. 23, 530–538 (2010).
Stutman, D., Beck, T. J., Carrino, J. A. & Bingham, C. O. Talbot phase-contrast X-ray imaging for the small joints of the hand. Phys. Med. Biol. 56, 5697–5720 (2011).
Nagashima, M. et al. Application of X-ray grating interferometry for the imaging of joint structures. Anat. Sci. Int. 89, 95–100 (2013).
Tanaka, J. et al. Cadaveric and in vivo human joint imaging based on differential phase contrast by X-ray Talbot-Lau interferometry. Z. Med. Phys. 23, 222–227 (2012).
Smolen, J. S. et al. Treating rheumatoid arthritis target: recommendations of an international task force. Ann. Rheum. Dis. 69, 631–637 (2010).
Jasvinder, A. S. et al. Update of the 2008 American College of Rheumatology recommendations for the use of disease-modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritis. Arthritis. Care. Res. 64, 625–639 (2012).
Gremese, E. et al. Very early rheumatoid arthritis as a predictor of remission: a multicentre real life prospective study. Ann. Rheum. Dis. 72, 858–862 (2013).
Bosello, S. et al. Very early rheumatoid arthritis is the major predictor of major outcomes: clinical ACR remission and radiographic non-progression. Ann. Rheum. Dis. 70, 1292–1295 (2011).
Monti, S., Montecucco, C., Bugatti, S. & Caporali, R. Rheumatoid arthritis treatment: the earlier the better to prevent joint damage. RMD Open. 1, e000057 (2015).
Vastesaeger, N., Xu, S., Aletaha, D., St Clair, E. W. & Smolen, J. S. A pilot risk model for the prediction of rapid radiographic progression in rheumatoid arthritis. Rheumatology (Oxford). 48, 1114–1121 (2009).
Emery, P. The Roche Rheumatology Prize Lecture. The optimal management of early rheumatoid disease: the key to preventing disability. Br. J. Rheumatol. 33, 765–768 (1994).
McGonagle, D. et al. The relationship between synovitis and bone changes in early untreated rheumatoid arthritis. Arthritis Rheum. 42, 1706–1711 (1999).
Boutry, N., Morel, M., Flipo, R., Demondion, X. & Cotton, A. Early rheumatoid arthritis: a review of MRI and sonographic findings. AJR Am. J. Roentgenol. 189, 1502–1509 (2007).
Rowbotham, E. L. & Grainger, A. J. Rheumatoid arthritis: ultrasound versus MRI. Am. J. Roentgenol. 197, 541–546 (2011).
Yashiro, W., Takeda, Y. & Momose, A. Efficiency of capturing a phase image using cone-beam x-ray Talbot interferometry. J. Opt. Soc. Am. A. Opt. Image Sci. Vis. 25, 2025–2039 (2008).
Pfeiffer, F. et al. Hard-X-ray dark-field imaging using a grating interferometer. Nat. Mat. 7, 134–137 (2008).
Larsen, A. et al. Radiographic evaluation of rheumatoid arthritis and related conditions by standard reference films. Acta. Radiol. Diagn. 18, 481–91 (1977).
We express gratitude to the radiologic technologists: Mr. Yukihito Wada, Mr. Hiroaki Kawasaki, Mr. Masaya Hirano, and Mr. Masato Endo of the Department of Radiology at Saitama Medical University. In addition, this study was supported by the SENTAN project of Japan Science and Technology Agency.We would like to thank Editage (www.editage.com) for English language editing.
Y.H., J.K., S.N., C.M., A.T., Y.S., N.M., and K.K. are employed by Konica Minolta, Inc. The company owns the following relevant patents: US 9044154 invented by Y.H. and S.N., and US 910763 invented by Y.H. H.Y., Y.K., Y.T.K., H.O., T.M., Y.A., T.M., J.T., M.N., and A.M. declare no potential conflict of interest.
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Yoshioka, H., Kadono, Y., Kim, Y.T. et al. Imaging evaluation of the cartilage in rheumatoid arthritis patients with an x-ray phase imaging apparatus based on Talbot-Lau interferometry. Sci Rep 10, 6561 (2020). https://doi.org/10.1038/s41598-020-63155-9
Scientific Reports (2021)